Veradigm股票讨论区

$Veradigm(MDRX.US)$2022年财报至今未出，5年来营收除2020年下滑8%以外增长了4年，平均增速仅有1.6%，营业利润从2018到2020年均亏损，2021年靠大幅削减费用扭亏达到0.89亿，净利润靠非经营收入达到1.3亿。
2022前3季度营收增长6.2%，营业利润萎缩40%，净利润受停止经营利润影响重新进入亏损区间。
财报延误通常不是好现象，加上近期财务数据的大起大落，暂时缺乏投资价值。

$Veradigm(MDRX.US)$ reports earnings for the last 3 months and a full year on February 25th. after recently pulling back I feel like this talk is at a good price point to make an entry and also try to front run the earnings call strategy groups who usually only seem to look a week ahead. this was a position I wanted to enter before I noticed this scenario so it works out well. having any kind of telemedicine in your portfolio right now is a good thing I think...